(Reuters) - A uterine surgical technique that has been linked with the spread of a rare type of cancer poses a serious concern to regulators that will be addressed this week by an advisory committee to the U.S. Food and Drug Administration. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/2ae54Atb8g4/story01.htm
Read More
No comments:
Post a Comment